Back to News & Events

The New York Academy of Sciences

Location


7 World Trade Center, 250 Greenwich Street, 40th floor
New York
NY
10007

Next Event

No upcoming events

Loading Map….

Upcoming Events

  • No events in this location
  • Related Stories

    WP_Query Object
    (
        [query] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
            )
    
        [query_vars] => Array
            (
                [post_type] => post
                [posts_per_page] => 3
                [post_status] => publish
                [orderby] => rand
                [error] => 
                [m] => 
                [p] => 0
                [post_parent] => 
                [subpost] => 
                [subpost_id] => 
                [attachment] => 
                [attachment_id] => 0
                [name] => 
                [pagename] => 
                [page_id] => 0
                [second] => 
                [minute] => 
                [hour] => 
                [day] => 0
                [monthnum] => 0
                [year] => 0
                [w] => 0
                [category_name] => 
                [tag] => 
                [cat] => 
                [tag_id] => 
                [author] => 
                [author_name] => 
                [feed] => 
                [tb] => 
                [paged] => 0
                [meta_key] => 
                [meta_value] => 
                [preview] => 
                [s] => 
                [sentence] => 
                [title] => 
                [fields] => 
                [menu_order] => 
                [embed] => 
                [category__in] => Array
                    (
                    )
    
                [category__not_in] => Array
                    (
                    )
    
                [category__and] => Array
                    (
                    )
    
                [post__in] => Array
                    (
                    )
    
                [post__not_in] => Array
                    (
                    )
    
                [post_name__in] => Array
                    (
                    )
    
                [tag__in] => Array
                    (
                    )
    
                [tag__not_in] => Array
                    (
                    )
    
                [tag__and] => Array
                    (
                    )
    
                [tag_slug__in] => Array
                    (
                    )
    
                [tag_slug__and] => Array
                    (
                    )
    
                [post_parent__in] => Array
                    (
                    )
    
                [post_parent__not_in] => Array
                    (
                    )
    
                [author__in] => Array
                    (
                    )
    
                [author__not_in] => Array
                    (
                    )
    
                [search_columns] => Array
                    (
                    )
    
                [ignore_sticky_posts] => 
                [suppress_filters] => 
                [cache_results] => 1
                [update_post_term_cache] => 1
                [update_menu_item_cache] => 
                [lazy_load_term_meta] => 1
                [update_post_meta_cache] => 1
                [nopaging] => 
                [comments_per_page] => 50
                [no_found_rows] => 
                [order] => 
            )
    
        [tax_query] => WP_Tax_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => AND
                [table_aliases:protected] => Array
                    (
                    )
    
                [queried_terms] => Array
                    (
                    )
    
                [primary_table] => wp_posts
                [primary_id_column] => ID
            )
    
        [meta_query] => WP_Meta_Query Object
            (
                [queries] => Array
                    (
                    )
    
                [relation] => 
                [meta_table] => 
                [meta_id_column] => 
                [primary_table] => 
                [primary_id_column] => 
                [table_aliases:protected] => Array
                    (
                    )
    
                [clauses:protected] => Array
                    (
                    )
    
                [has_or_relation:protected] => 
            )
    
        [date_query] => 
        [request] => 
    					SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
    					FROM wp_posts 
    					WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
    					
    					ORDER BY RAND()
    					LIMIT 0, 3
    				
        [posts] => Array
            (
                [0] => WP_Post Object
                    (
                        [ID] => 4285
                        [post_author] => 4
                        [post_date] => 2023-09-11 12:13:16
                        [post_date_gmt] => 2023-09-11 16:13:16
                        [post_content] => 
    

    Join Stony Brook University’s Intellectual Property Partners on Thursday, October 12, from 4:30 pm to 6 pm at the Charles B. Wang Center at Stony Brook University for the panel discussion titled “Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing.”

    The event will be hosted by Intellectual Property Partners (IPP), the SBU Chapter of the National Academy of Inventors (NAI), and the Manufacturing and Technology Resource Consortium (MTRC) and will be followed by a networking cocktail reception from 6 pm to 7 pm.

    Moderated by Dr. James Hayward, President, CEO and Chairman of Applied DNA Sciences, panelists include:
    – Adrian Howansky, PhD, Clinical Medical Physicist, Department of Radiology, Stony Brook University Hospital
    – Doreen Swift, Senior Director, Embedded Software Engineering, IPS
    – Michael R. Bielski, President, DevTech Partners
    – Nariman Boyle, MD, Director, Ophthalmic Plastic Orbit and Reconstructive Surgery, Department of Ophthalmology, Renaissance School of Medicine, Stony Brook University
    – Paul Schwartz, Director, Advanced Propulsion Technologies

    This event is free and open to Stony Brook University attendees. Space is limited and registration is required. Register here to secure your spot.

    For more information visit: https://www.stonybrook.edu/commcms/ipp/Events/Manufacturing.php

    [post_title] => "Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing" 10/12/23 [post_excerpt] => Join Stony Brook University’s Intellectual Property Partners on October 12th for the panel discussion titled “Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing.” [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bring-your-new-technology-innovations-to-life-through-prototyping-and-manufacturing-10-12-23 [to_ping] => [pinged] => [post_modified] => 2023-11-15 11:24:35 [post_modified_gmt] => 2023-11-15 16:24:35 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4285 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 2510 [post_author] => 4 [post_date] => 2016-11-30 19:37:58 [post_date_gmt] => 2016-11-30 19:37:58 [post_content] => Codagenix, Inc. has entered into an exclusive licensing agreement with Stony Brook University, through the Research Foundation for the State of New York, to commercialize a platform technology to develop a pipeline of live attenuated vaccines against viral infections in people and animals. The technology relies on software to re-design the genomes of potentially harmful viruses to make them safe and effective vaccines. The technology stems from research in the laboratory of Eckard Wimmer, PhD, Distinguished Professor in the Department of Molecular Genetics & Microbiology. The lead indication for vaccine development generated is a vaccine against Seasonal Influenza slated for Phase I human clinical trials in 2017. Dr. Wimmer, along with Steffen Mueller, PhD, Codagenix President and Chief Science Officer, and J. Robert Coleman, PhD, Codagenix Chief Operating officer, worked as colleagues for years in Dr. Wimmer’s laboratory examining and experimenting with the genes of viruses. By collaborating with Stony Brook scientists Bruce Futcher, PhD, in the Department of Molecular Genetics & Microbiology, and Steven Skienna, PhD, in the Department of Computer Science, they discovered a way using gene manipulation and computer algorithms to “re-code” the genes of viruses. This re-coding process makes viruses extremely weak and thus ideal candidates as ultra-low dose attenuated vaccines. The licensing agreement enables Codgenix to develop and potentially market next generation vaccines using software-based gene design and whole viral synthesis to create low-dose, attenuated virus vaccines. The company expects to use this design to first test its vaccine against influenza; however, there are plans for human testing of their Zika and other vaccine candidates. Codagenix is also in partnership with a large agricultural company to make vaccines using the technology for companion and agricultural animals. The technology has been shown to be effective against numerous viruses including ZIka, Dengue, and RSV all of which are in preclinical testing. The development of this pipeline of vaccines can be seen in numerous scientific papers since 2008, including a paper in Science, PNAS, National Biotechnology and most recently in 2015 in MBIo. Read Stony Brook University's full press release here.  [post_title] => Codagenix Inks Exclusive License Agreement [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => codagenix-inks-exclusive-license-agreement [to_ping] => [pinged] => [post_modified] => 2017-03-15 13:49:05 [post_modified_gmt] => 2017-03-15 13:49:05 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2510 [menu_order] => 157 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2237 [post_author] => 3 [post_date] => 2016-06-07 15:14:28 [post_date_gmt] => 2016-06-07 15:14:28 [post_content] => Traverse Biosciences has announced that it has secured $500,000 in convertible debt financing to support operations and advance product development efforts. The seed financing was led by Excell Partners, with matching funds from a number of individual accredited angel investors. The Research Foundation for the State of New York (RF/SUNY) also participated in the financing, as part of an exclusive license and option agreement executed last year that gave Traverse Biosciences access to the relevant intellectual property for use in animal and human health. Traverse Biosciences, which began when CEO Joseph Scaduto was serving as a BioEntrepreneur-in-Residence for the Center for Biotechnology, is working to commercialize its proprietary library of Stony Brook University invented chemically-modified curcumins for the treatment of chronic inflammatory conditions and cancers affecting humans and animals. Read more about Traverse and the recent financing:     [post_title] => Traverse Biosciences Secures $500k Seed Financing [post_excerpt] => Traverse Biosciences announced that it has secured $500,000 in convertible debt financing to support operations and advance product development efforts. The seed financing was led by Excell Partners, with matching funds from a number of individual accredited angel investors. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => traverse-biosciences-secures-500k-seed-financing [to_ping] => [pinged] => [post_modified] => 2016-06-07 15:14:28 [post_modified_gmt] => 2016-06-07 15:14:28 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2237 [menu_order] => 177 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 1417 [post_author] => 3 [post_date] => 2015-02-19 19:17:30 [post_date_gmt] => 2015-02-19 19:17:30 [post_content] => Presented by Clean Energy Business Incubator Program Wednesday, March 11, 2015 Long Island High Tech Incubator 3:30 PM - 5:00 PM: Seminar 5:00 PM - 7:00 PM: Mixer In most cases for a startup, having patent, trade secret, trademark, and/or copyright protection is the key leverage needed to attract the life-blood investment necessary to sustain and grow the startup to exit. This discussion will address from a startup's perspective how to maintain the maximum potential value of Intellectual Property you may have AND future Intellectual Property that you don't even know about yet! You will learn about:
    • Patent, Trademark, Copyright and Trade Secret Basics
    • Common misconceptions about IP, e.g., Patentability and enforcement vs. Freedom-to-Operate
    • Preparing for your pitch and the resultant Due Diligence
    • What steps to take (or not to take) in order to avoid losing your precious IP leverage: Unintentionally forfeiting IP rights,Controlling ownership,And other IP portfolio building strategies
    Speakers: Ray Farrell, founding partner of Carter, DeLuca, Farrell & Schmidt, LLP; Pina Campagna, Patent & Trademark Attorney at Carter, DeLuca, Farrell & Schmidt, LLP. RSVP to David C Hamilton Director, Business Development, Clean Energy Business Incubator Program (CEBIP): david.hamilton@stonybrook.edu [post_title] => Startup Mission Critical: How to build an IP portfolio investors will want to invest in early and often [post_excerpt] => In most cases for a startup, having patent, trade secret, trademark, and/or copyright protection is the key leverage needed to attract the life-blood investment necessary to sustain and grow the startup to exit. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => startup-mission-critical-how-to-build-an-ip-portfolio-investors-will-want-to-invest-in-early-and-often [to_ping] => [pinged] => [post_modified] => 2016-03-02 18:02:01 [post_modified_gmt] => 2016-03-02 18:02:01 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/new/?p=1417 [menu_order] => 214 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4285 [post_author] => 4 [post_date] => 2023-09-11 12:13:16 [post_date_gmt] => 2023-09-11 16:13:16 [post_content] =>

    Join Stony Brook University’s Intellectual Property Partners on Thursday, October 12, from 4:30 pm to 6 pm at the Charles B. Wang Center at Stony Brook University for the panel discussion titled “Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing.”

    The event will be hosted by Intellectual Property Partners (IPP), the SBU Chapter of the National Academy of Inventors (NAI), and the Manufacturing and Technology Resource Consortium (MTRC) and will be followed by a networking cocktail reception from 6 pm to 7 pm.

    Moderated by Dr. James Hayward, President, CEO and Chairman of Applied DNA Sciences, panelists include:
    – Adrian Howansky, PhD, Clinical Medical Physicist, Department of Radiology, Stony Brook University Hospital
    – Doreen Swift, Senior Director, Embedded Software Engineering, IPS
    – Michael R. Bielski, President, DevTech Partners
    – Nariman Boyle, MD, Director, Ophthalmic Plastic Orbit and Reconstructive Surgery, Department of Ophthalmology, Renaissance School of Medicine, Stony Brook University
    – Paul Schwartz, Director, Advanced Propulsion Technologies

    This event is free and open to Stony Brook University attendees. Space is limited and registration is required. Register here to secure your spot.

    For more information visit: https://www.stonybrook.edu/commcms/ipp/Events/Manufacturing.php

    [post_title] => "Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing" 10/12/23 [post_excerpt] => Join Stony Brook University’s Intellectual Property Partners on October 12th for the panel discussion titled “Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing.” [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bring-your-new-technology-innovations-to-life-through-prototyping-and-manufacturing-10-12-23 [to_ping] => [pinged] => [post_modified] => 2023-11-15 11:24:35 [post_modified_gmt] => 2023-11-15 16:24:35 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4285 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 249 [max_num_pages] => 83 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

    “Bring Your New Technology Innovations to Life Through Prototyping and Manufacturing” 10/12/23

    More Information

    Codagenix Inks Exclusive License Agreement

    More Information

    Traverse Biosciences Secures $500k Seed Financing

    More Information

    Startup Mission Critical: How to build an IP portfolio investors will want to invest in early and often

    More Information